... San Antonio Breast Cancer Symposium, Showcasing Precision Tools for ... BostonGene is a biotechnology company specializing in advanced computational ...
News
- BostonGene Unveils Transformative Breast Cancer Research at 2024 San Antonio ... - Morningstar
- ALX Oncology Announces New Data Demonstrating Evorpacept in Combination ... - StreetInsider
(“ALX Oncology” or “the Company”) (Nasdaq: ALXO), a clinical-stage biotechnology ... San Antonio Breast Cancer Symposium (SABCS). “These data suggest ...
- SA's BioBridge Global to launch new subsidiary - San Antonio Business Journal
In a move expected to strengthen and expand San Antonio's standing in the international biotech arena, BioBridge Global plans to merge its cell ...
- BIO-TECHNE LAUNCHES ESR1 MUTATION MONITORING ASSAY - PR Newswire
Company will showcase new assay at the upcoming San Antonio Breast Cancer Symposium. MINNEAPOLIS, Dec. 10, 2024 /PRNewswire/ -- Bio-Techne ...
- Tempus Announces Four Abstracts Accepted for Presentation at the 2024 San Antonio ...
... San Antonio Breast Cancer Symposium, which convenes from December 10-13, in San Antonio, Texas. "Presenting our latest research at the San Antonio ...